Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Liabilities (2019 - 2025)

Cresco Labs' Total Liabilities history spans 7 years, with the latest figure at $944.8 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 2.31% year-over-year to $944.8 million; the TTM value through Dec 2025 reached $944.8 million, down 2.31%, while the annual FY2025 figure was $944.8 million, 2.31% down from the prior year.
  • Total Liabilities reached $944.8 million in Q4 2025 per CRLBF's latest filing, down from $967.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $996.0 million in Q4 2022 to a low of $930.4 million in Q4 2023.
  • Average Total Liabilities over 5 years is $964.2 million, with a median of $967.2 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: surged 49.52% in 2021, then dropped 6.59% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $982.7 million in 2021, then rose by 1.35% to $996.0 million in 2022, then decreased by 6.59% to $930.4 million in 2023, then rose by 3.95% to $967.2 million in 2024, then decreased by 2.31% to $944.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Total Liabilities are $944.8 million (Q4 2025), $967.2 million (Q4 2024), and $930.4 million (Q4 2023).